IRS1 and leiomyoma: It has been reported that IRS-1 is highly expressed and active in a variety of tumors, including hepatocellular carcinomas (HCCs), breast cancers, pancreatic cancer, colon cancer, liposarcomas, leiomyomas and adrenal cortical carcinomas [28–30].